Published April 29, 2022 | Version v1

Intrarenal injection of silica mesoporous reduced renal toxicity induced by gentamycin in rats

  • 1. Department of zoology, Faculty of science, Sirte University. Sirte Libya.
  • 2. Department of Zoology. Faculty of Science, Cairo University, Egypt.
  • 3. Faculty of Pharmacy, Cairo University, Egypt.

Description

Introduction: Mesoporous silica (MS) has recently used in biomedical applications due to its distinctive physicochemical properties.

Purpose: The study aims to investigate the efficacy of MS to reduce renal toxicity induced by gentamicin in rats.

Methods: The rats were randomly divided into three groups (n=6 per group): Control group (injected with 0.9% saline i.p daily for 8 consecutive), Gentamycin (injected with gentamycin, 100 mg/kg bw i.p. for 8 consecutive days) and MS group (after gentamycin injection, rat injected into left kidney with MS; 70 μg/0.5 ml/ rat).

Results: Ms Treatment caused significant decreases in creatinine, urea, uric acid, and MDA while it increased GSH and catalase levels.

Conclusion: Intrarenal injection of MS improved renal function in rats suffering from acute kidney injury.

Files

GSCBPS-2022-0138.pdf

Files (970.4 kB)

Name Size
md5:3adcdce255919aa5b6dfe8248fcae613
970.4 kB Preview Download

Additional details